BIOA INVESTOR DEADLINE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
BreakPoint Labs Awarded SeaPort Next Generation (NxG) Prime Contract
BreakPoint Labs, LLC ("BreakPoint Labs"), a technically proficient, mission-focused cybersecurity service provider, is ...
Nadcab Labs Sets New Standard in Blockchain Innovation with Advanced Smart Contract Services
A new benchmark in blockchain innovation is being set with advanced smart contract services. Offering expert auditing and ...
Needham Sticks to Its Hold Rating for Proto Labs (PRLB)
Needham analyst James Ricchiuti maintained a Hold rating on Proto Labs (PRLB – Research Report) today. The company’s shares closed today at ...